Nektar Therapeutics reported $986.14M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Agios Pharmaceuticals AGIO:US $ 1305.29M 397.28M
ALKERMES ALKS:US 1.05B 15.25M
Amgen AMGN:US $ 24380M 5281M
Astrazeneca AZN:US 26.69B 583M
Baxter International BAX:US $ 8167M 163M
Biogen BIIB:US $ 7162.3M 21.4M
Bluebird Bio BLUE:US $ 832.32M 71.2M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Cara Therapeutics CARA:US $ 171.5M 7.03M
Eisai 4523:JP Y 570717M 8210M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Esperion Therapeutics ESPR:US $ 170.67M 104.51M
Exelixis EXEL:US $ 1662.03M 68.78M
Gilead Sciences GILD:US $ 14200M 275M
GlaxoSmithKline GSK:LN 18.25B 688M
Halozyme Therapeutics HALO:US $ 1017.3M 17.55M
Immunogen IMGN:US $ 296.8M 22.41M
IONIS PHARMACEUT IONS:US $ 2156M 82.42M
Ironwood Pharmaceuticals IRWD:US $ 695.37M 75.11M
Karyopharm Therapeutics KPTI:US $ 241.58M 31.92M
Macrogenics MGNX:US $ 334.7M 32.3M
Mirati Therapeutics MRTX:US $ 1171.89M 106.2M
Nektar Therapeutics NKTR:US $ 986.14M 70.01M
Neurocrine Biosciences NBIX:US $ 1005.7M 104.4M
Novartis NOVN:VX 26.25B 2.45B
Sarepta Therapeutics SRPT:US $ 2185.31M 79.91M
Seattle Genetics SGEN:US $ 3114.61M 16.1M
Takeda 4502:JP Y 2456353M 20105M
Teva Pharmaceutical TEVA:IT 12.15B 668M
Xencor XNCR:US $ 329.63M 151.34M
YTE INCY:US $ 2923.8M 303.74M